BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 30261750)

  • 1. Neutrophil gelatinase-associated lipocalin (NGAL) and cardiovascular events in patients with stable coronary artery disease.
    Sivalingam Z; Erik Magnusson N; Grove EL; Hvas AM; Dalby Kristensen S; Bøjet Larsen S
    Scand J Clin Lab Invest; 2018 Oct; 78(6):470-476. PubMed ID: 30261750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma neutrophil gelatinase-associated lipocalin levels are associated with the presence and severity of coronary heart disease.
    Li C; Zhang Z; Peng Y; Gao H; Wang Y; Zhao J; Pan C
    PLoS One; 2019; 14(8):e0220841. PubMed ID: 31387110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum neutrophil gelatinase-associated lipocalin is associated with cardiovascular events in patients with chronic kidney disease.
    Solak Y; Yilmaz MI; Siriopol D; Saglam M; Unal HU; Yaman H; Gok M; Cetinkaya H; Gaipov A; Eyileten T; Sari S; Yildirim AO; Tonbul HZ; Turk S; Covic A; Kanbay M
    Int Urol Nephrol; 2015 Dec; 47(12):1993-2001. PubMed ID: 26498629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating osteoglycin and NGAL/MMP9 complex concentrations predict 1-year major adverse cardiovascular events after coronary angiography.
    Cheng JM; Akkerhuis KM; Meilhac O; Oemrawsingh RM; Garcia-Garcia HM; van Geuns RJ; Piquer D; Merle D; du Paty E; Galéa P; Jaisser F; Rossignol P; Serruys PW; Boersma E; Fareh J; Kardys I
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1078-84. PubMed ID: 24651681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma neutrophil gelatinase-associated lipocalin levels in acute myocardial infarction and stable coronary artery disease.
    Sahinarslan A; Kocaman SA; Bas D; Akyel A; Ercin U; Zengin O; Timurkaynak T
    Coron Artery Dis; 2011 Aug; 22(5):333-8. PubMed ID: 21558855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of neutrophil gelatinase-associated lipocalin and sdLDL-C for coronary artery disease in patients with type 2 diabetes mellitus aged ≥ 65 years.
    Chen Y; Fu Y; Wang S; Chen P; Pei Y; Zhang J; Zhang R; Niu G; Gu F; Li X
    Cardiovasc Diabetol; 2022 Nov; 21(1):252. PubMed ID: 36397150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil gelatinase-associated lipocalin levels are U-shaped in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study-Impact for mortality.
    Woitas RP; Scharnagl H; Kleber ME; Delgado GE; Grammer TB; Pichler M; Krämer BK; März W; Stojakovic T
    PLoS One; 2017; 12(2):e0171574. PubMed ID: 28207778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Lindberg S; Pedersen SH; Mogelvang R; Jensen JS; Flyvbjerg A; Galatius S; Magnusson NE
    J Am Coll Cardiol; 2012 Jul; 60(4):339-45. PubMed ID: 22813613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure.
    Ivanes F; Susen S; Mouquet F; Pigny P; Cuilleret F; Sautière K; Collet JP; Beygui F; Hennache B; Ennezat PV; Juthier F; Richard F; Dallongeville J; Hillaert MA; Doevendans PA; Jude B; Bertrand M; Montalescot G; Van Belle E
    Eur Heart J; 2012 Jan; 33(2):191-202. PubMed ID: 21719456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Associations of Blood Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin with Progression from CKD to ESRD.
    Alderson HV; Ritchie JP; Pagano S; Middleton RJ; Pruijm M; Vuilleumier N; Kalra PA
    Clin J Am Soc Nephrol; 2016 Dec; 11(12):2141-2149. PubMed ID: 27852662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of neutrophil gelatinase-associated lipocalin in ST-segment elevation myocardial infarction.
    Akcay AB; Ozlu MF; Sen N; Cay S; Ozturk OH; Yalcn F; Bilen P; Kanat S; Karakas MF; Isleyen A; Demir AD; Sogut S; Covic A; Kanbay M
    J Investig Med; 2012 Feb; 60(2):508-13. PubMed ID: 22222228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of neutrophil gelatinase-associated lipocalin and glycosylated hemoglobin for non-ST-segment elevation myocardial infarction patients with single concomitant chronic total occlusion following primary percutaneous coronary intervention: A prospective observational study.
    Peng W; Zhang C; Wang Z; Yang W; Luo H; Li X; Fu D; Yu C; Zhou Y
    Medicine (Baltimore); 2019 Sep; 98(39):e16982. PubMed ID: 31574797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma neutrophil gelatinase-associated lipocalin: a marker of acute pyelonephritis in children.
    Kim BK; Yim HE; Yoo KH
    Pediatr Nephrol; 2017 Mar; 32(3):477-484. PubMed ID: 27744618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma neutrophil gelatinase-associated lipocalin as a predictive biomarker for the detection of acute kidney injury in adult poisoning.
    Ahn JY; Lee MJ; Seo JS; Choi D; Park JB
    Clin Toxicol (Phila); 2016; 54(2):127-33. PubMed ID: 26683351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma cystatin C and neutrophil gelatinase-associated lipocalin in relation to coronary atherosclerosis on intravascular ultrasound and cardiovascular outcome: Impact of kidney function (ATHEROREMO-IVUS study).
    Brankovic M; Akkerhuis KM; Buljubasic N; Cheng JM; Oemrawsingh RM; Garcia-Garcia HM; Regar E; Serruys PW; van Geuns RJ; Boersma E; Kardys I
    Atherosclerosis; 2016 Nov; 254():20-27. PubMed ID: 27680774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calprotectin and Neutrophil Gelatinase-Associated Lipocalin As Biomarkers of Acute Kidney Injury in Acute Coronary Syndrome.
    Zhen XW; Song NP; Ma LH; Ma LN; Guo L; Yang XD
    Am J Med Sci; 2021 Jun; 361(6):736-743. PubMed ID: 33892917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early diagnostic value of neutrophil gelatinase-associated lipocalin and interleukin-18 in patients with sepsis-induced acute kidney injury].
    Zhu L; Shi D
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Aug; 28(8):718-22. PubMed ID: 27434563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of neutrophil gelatinase-associated lipocalin and B-type natriuretic in patients with ST-elevation myocardial infarction treated by primary PCI: a prospective observational cohort study.
    Helanova K; Littnerova S; Kubena P; Ganovska E; Pavlusova M; Kubkova L; Jarkovsky J; Pavkova Goldbergova M; Lipkova J; Gottwaldova J; Kala P; Toman O; Dastych M; Spinar J; Parenica J
    BMJ Open; 2015 Oct; 5(10):e006872. PubMed ID: 26438132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary calprotectin, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin for the prediction of adverse outcome in pediatric acute kidney injury.
    Westhoff JH; Seibert FS; Waldherr S; Bauer F; Tönshoff B; Fichtner A; Westhoff TH
    Eur J Pediatr; 2017 Jun; 176(6):745-755. PubMed ID: 28409285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease.
    Malyszko J; Bachorzewska-Gajewska H; Malyszko JS; Pawlak K; Dobrzycki S
    Nephrology (Carlton); 2008 Apr; 13(2):153-6. PubMed ID: 18275504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.